Cyclomune is an oral immunosuppressive medication that contains the active compound cyclosporine. It is prescribed primarily to prevent graft rejection after organ transplantation. The drug modulates the activity of t lymphocytes by inhibiting the enzyme calcineurin. This inhibition reduces the production of cytokines that drive immune activation and inflammation. By dampening these immune responses the medication helps maintain the function of transplanted organs while sparing normal immune surveillance. The overall therapeutic effect results from the selective suppression of immune signaling pathways that mediate organ rejection.

Cyclomune is an oral medication that contains cyclosporine, a drug used to suppress the immune system in patients who have received organ transplants. It works by inhibiting the activation of t-cells, which are white blood cells that drive the body's rejection response. The active ingredient binds to cyclophilin inside t-cells, forming a complex that blocks the enzyme calcineurin and prevents the transcription of interleukin genes. Without interleukin production, the downstream immune signaling pathways that mobilize immune cells are reduced. This selective suppression helps maintain graft viability while preserving most of the normal immune defenses. The drug's pharmacokinetics involve extensive metabolism in the liver and elimination through the bile, leading to relatively long plasma concentrations. Because of its targeted action on immune modulation, Cyclomune serves as a cornerstone therapy for preventing transplant rejection.

Cyclomune may cause mild swelling of the gums in some patients. Headache is reported as a frequent complaint among users. Elevated blood pressure can occur as a common systemic effect. Some individuals experience temporary changes in taste sensation. Skin rashes or itching are observed at a moderate frequency. Slight weight gain is noted in a portion of patients during long term use. Tremors or shaking of the hands have been recorded as occasional side effects.

Common side effects of Cyclomune often include headache and nausea. Some patients report mild tremor or shaking of the hands. Elevated blood pressure is frequently observed during treatment. Gum overgrowth or swelling may occur in long-term users. The medication can increase the risk of infections due to immune modulation. Fatigue and occasional dizziness are also reported among users. Laboratory monitoring of kidney function is typically recommended for safety.